Your browser doesn't support javascript.
loading
Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke.
Eldahshan, Wael; Sayed, Mohammed A; Awad, Mohamed E; Ahmed, Heba A; Gillis, Ellen; Althomali, Waleed; Pillai, Bindu; Alshammari, Abdulkarim; Jackson, Ladonya; Dong, Guangkuo; Sullivan, Jennifer C; Cooley, Marion A; Elsalanty, Mohammed; Ergul, Adviye; Fagan, Susan C.
Afiliação
  • Eldahshan W; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Sayed MA; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Awad ME; Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Ahmed HA; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America.
  • Gillis E; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Althomali W; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Pillai B; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Alshammari A; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Jackson L; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America.
  • Dong G; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Sullivan JC; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Cooley MA; Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA, United States of America.
  • Elsalanty M; Department of Medical Anatomical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Medical Sciences, Pomona, CA, United States of America.
  • Ergul A; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States of America; Ralph H. Johnson VA Medical Center, Charleston, SC, United States of America.
  • Fagan SC; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States of America; Charlie Norwood VA Medical Center, Augusta University, Augusta, GA, United States of America. Electronic address: sfagan@augusta.edu.
Vascul Pharmacol ; 141: 106904, 2021 12.
Article em En | MEDLINE | ID: mdl-34481068
ABSTRACT
Angiotensin signaling is known to be sexually dimorphic. Although it is a well-studied target for intervention in stroke and cognitive impairment, female studies are rare. With females suffering a disproportionately greater negative impact of stroke and dementia vs. males, effective interventions are of utmost urgency. The aim of the current study was to determine the impact of activation of the angiotensin II type 2 receptor (AT2R) with the agonist compound 21 (C21) on the development of post-stroke cognitive impairment, after experimental ischemic stroke. Ovariectomized (OVX) spontaneously hypertensive rats (SHRs) were subjected to 1 h of middle cerebral artery occlusion (MCAO). At 24 h, rats with a significant neurologic deficit were randomized to receive either saline or C21 (0.03 mg/kg/day) intraperitoneally (IP) for 5 days, then orally (0.12 mg/kg/day) for a total of 6 weeks. Cognitive function, brain structure by MRI and vascular architecture by microCT angiography were measured. C21 preserved cognitive function, specifically spatial memory, and improved vascular density in the ischemic hemisphere at 6 weeks, reflecting both arteriogenesis and angiogenesis. In conclusion, C21 prevented cognitive impairment after stroke, likely through a mechanism involving vascular protection and restoration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Angiotensina / Acidente Vascular Cerebral Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Vascul Pharmacol Assunto da revista: ANGIOLOGIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Angiotensina / Acidente Vascular Cerebral Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Vascul Pharmacol Assunto da revista: ANGIOLOGIA / FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos